Soliqua Solostar Pens

Soliqua SoloStar Pens are prefilled injectable devices that combine insulin glargine, a long-acting basal insulin, and lixisenatide, a GLP-1 receptor agonist. This combination is designed to improve blood sugar control in adults with type 2 diabetes. Soliqua offers a convenient and effective dual-action solution by addressing both fasting and post-meal blood sugar levels.

Benefits:

• Combines long-acting insulin with a GLP-1 receptor agonist for comprehensive blood sugar control
• Helps manage both fasting and post-meal glucose levels
• Reduces the need for multiple daily injections with a single daily dose
• May aid in weight loss due to appetite suppression from lixisenatide
• Provides adjustable dosing tailored to individual needs

Dosage:

• For patients switching from less than 30 units of basal insulin, the starting dose is 15 units (15-5 combination)
• For patients switching from 30–60 units of basal insulin, the starting dose is 30 units (30-10 combination)
• Maximum daily dose is 60 units of Soliqua
• Administer once daily within an hour before the first meal of the day
• Dosage adjustments are based on blood sugar levels and your healthcare provider’s recommendations

Usage Instructions:

• Use Soliqua SoloStar Pens exactly as prescribed by your healthcare provider
• Inject subcutaneously in the abdomen, thigh, or upper arm and rotate injection sites to prevent tissue damage
• Prime the pen before injecting to ensure accurate dosing
• If you miss a dose, skip it and take your next dose at the usual time without doubling up
• Follow your healthcare provider’s guidance for proper injection techniques

Storage Information:

• Store unused pens in the refrigerator between 36°F and 46°F (2°C to 8°C)
• After opening, store the pen at room temperature (below 86°F or 30°C) and use within 28 days
• Keep away from direct sunlight and heat sources. Do not freeze
• Dispose of pens after their expiration date or if they have been frozen

Warnings and Precautions:

• Avoid using Soliqua if you are allergic to insulin glargine, lixisenatide, or its ingredients
• Soliqua is not suitable for people with type 1 diabetes or diabetic ketoacidosis
• Regularly monitor blood sugar levels to prevent hypoglycemia or hyperglycemia
• Inform your healthcare provider of all medications you are taking, as some may interact with Soliqua
• Be aware of low blood sugar risks, especially when used with other diabetes medications
• Avoid Soliqua if you have severe gastrointestinal issues or a history of pancreatitis

Common Side Effects:

• Low blood sugar (hypoglycemia)
• Nausea, vomiting, or diarrhea
• Stomach pain or discomfort
• Injection site reactions, including redness or swelling
• Headache or mild allergic reactions such as rash
• Seek immediate medical attention for severe allergic reactions